189
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

A Candidemia Case Caused by a Novel Drug-Resistant Candida auris with the Y132F Mutation in Erg11 in Mainland China

, , , ORCID Icon, , & show all
Pages 3065-3072 | Received 10 Mar 2023, Accepted 10 May 2023, Published online: 18 May 2023

References

  • Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–44. doi:10.1111/j.1348-0421.2008.00083.x
  • Spivak ES, Hanson KE. Candida auris: an emerging fungal pathogen. J Clin Microbiol. 2018;56(2). doi:10.1128/jcm.01588-17
  • Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G. Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020;16(10):e1008921. doi:10.1371/journal.ppat.1008921
  • Forsberg K, Woodworth K, Walters M, et al. Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2019;57(1):1–12. doi:10.1093/mmy/myy054
  • Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 2021;9(4). doi:10.3390/microorganisms9040807
  • Tsay S, Kallen A, Jackson BR, Chiller TM, Vallabhaneni S. Approach to the investigation and management of patients with candida auris, an emerging multidrug-resistant yeast. Clin Infect Dis. 2018;66(2):306–311. doi:10.1093/cid/cix744
  • Rudramurthy SM, Chakrabarti A, Paul RA, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017;72(6):1794–1801. doi:10.1093/jac/dkx034
  • de Jong AW, Hagen F. Attack, defend and persist: how the fungal pathogen Candida auris was able to emerge globally in healthcare environments. Mycopathologia. 2019;184(3):353–365. doi:10.1007/s11046-019-00351-w
  • Al-Obaid I, Asadzadeh M, Ahmad S, et al. Fatal breakthrough candidemia in an immunocompromised patient in Kuwait Due to Candida auris exhibiting reduced susceptibility to echinocandins and carrying a novel mutation in hotspot-1 of FKS1. J Fungi. 2022;8(3). doi:10.3390/jof8030267
  • Saris K, Meis JF, Voss A. Candida auris. Curr Opin Infect Dis. 2018;31(4):334–340. doi:10.1097/qco.0000000000000469
  • Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019;25(9):1780–1781. doi:10.3201/eid2509.190686
  • Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect. 2018;7(1):93. doi:10.1038/s41426-018-0095-0
  • Du H, Bing J, Nobile CJ, Huang G. Candida auris infections in China. Virulence. 2022;13(1):589–591. doi:10.1080/21505594.2022.2054120
  • Zhang L, Chen T, Wang Y, et al. Comparison analysis of different DNA Extraction methods on suitability for long-read metagenomic nanopore sequencing. Front Cell Infect Microbiol. 2022;12:919903. doi:10.3389/fcimb.2022.919903
  • Fan S, Zhan P, Bing J, et al. A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of Candida auris isolated from Beijing, China. Virulence. 2021;12(1):1388–1399. doi:10.1080/21505594.2021.1928410
  • Lone SA, Ahmad A. Candida auris-The growing menace to global health. Mycoses. 2019;62(8):620–637. doi:10.1111/myc.12904
  • Wickes BL. Analysis of a Candida auris outbreak provides new insights into an emerging pathogen. J Clin Microbiol. 2020;58(4). doi:10.1128/jcm.02083-19
  • Bandara N, Samaranayake L. Emerging and future strategies in the management of recalcitrant Candida auris. Med Mycol. 2022;60(4). doi:10.1093/mmy/myac008
  • Sunamura EI, Iwasaki M, Shiina S, et al. A novel enzyme immunoassay for the measurement of plasma (1 → 3)-β-D-glucan levels. J Immunol Methods. 2020;487:112872. doi:10.1016/j.jim.2020.112872
  • Bing J, Wang S, Xu H, et al. A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology. 2022;13(1):68–75. doi:10.1080/21501203.2021.1994479
  • Rybak JM, Sharma C, Doorley LA, Barker KS, Palmer GE, Rogers PD. Delineation of the direct contribution of Candida auris ERG11 mutations to clinical triazole resistance. Microbiol Spectr. 2021;9(3):e0158521. doi:10.1128/Spectrum.01585-21
  • Chen Y, Zhao J, Han L, et al. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. J Infect. 2018;77(6):561–571. doi:10.1016/j.jinf.2018.09.002
  • Huang G. Regulation of phenotypic transitions in the fungal pathogen Candida albicans. Virulence. 2012;3(3):251–261. doi:10.4161/viru.20010
  • Whiteway M, Bachewich C. Morphogenesis in Candida albicans. Annu Rev Microbiol. 2007;61:529–553. doi:10.1146/annurev.micro.61.080706.093341
  • Thompson DS, Carlisle PL, Kadosh D. Coevolution of morphology and virulence in Candida species. Eukaryotic Cell. 2011;10(9):1173–1182. doi:10.1128/ec.05085-11
  • Biswas S, Van Dijck P, Datta A. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. MMBR. 2007;71(2):348–376. doi:10.1128/mmbr.00009-06
  • Fan S, Yue H, Zheng Q, et al. Filamentous growth is a general feature of Candida auris clinical isolates. Med Mycol. 2021;59(7):734–740. doi:10.1093/mmy/myaa116